Skip to content
Maui Sky – Lifestyle
Author:
Hemab Therapeutics, Inc.
Hemab Therapeutics Reports First Quarter 2026 Financial Results
May 21, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
April 30, 2026